Here is the complete overview of Tenofovir Alafenamide Fumarate (TAF) Tablet 25 mg with icons:
💊 Tenofovir Alafenamide (TAF) Tablet 25 mg
🧪 Nature / Drug Class
🔹 Antiviral / Antiretroviral Agent
🔹 Nucleotide Reverse Transcriptase Inhibitor (NRTI)
🔹 A prodrug of tenofovir — more targeted, lower systemic toxicity than TDF
🩺 Purpose / Indications
✅ Used in the management of:
- 🦠 Chronic Hepatitis B Virus (HBV) infection
- 🧬 HIV-1 infection, as part of combination therapy
⚙️ Advantages
✔️ Lower dose than TDF with similar efficacy
✔️ Reduced renal toxicity and better bone safety profile
✔️ Suitable for long-term therapy
✔️ Can be used in patients with mild-to-moderate renal impairment
📦 Common Packaging
📦 Tablet: 25 mg
💊 Supplied in blister packs or bottles (usually 30 tablets per bottle)
⚠️ Patient Advice / Precautions
🕐 Take once daily, with or without food
➕ Always used in combination for HIV, but can be used alone for HBV
🧪 Monitor:
- Liver enzymes
- HBV DNA or HIV viral load
- Renal function (though safer than TDF)
⚠️ Do not discontinue suddenly – may cause HBV flare in co-infected individuals
👶 Not approved for use in children under 12 years (unless specified)
🧊 Storage
🌡️ Store at room temperature
🚫 Keep away from moisture and sunlight
🧒 Keep out of reach of children